FDA Inspection
CSL Plasma IncCSL Plasma Inc – FDA Inspection, Feb 6, 2026
Record Details
This FDA Inspection record concerns CSL Plasma Inc, with an inspection on February 6, 2026, issued by the Philadelphia District Office, covering biologics.
View Company Profile
ID · a25553f6-69b8-4e81-a1e3-a9201198101d
Inspection Facts
- Inspection number
- 1302188
- FDA center
- Biologics
- Project area
- Blood and Blood Products
- Outcome
- Form 483 issued
FDA Citations
2- 21 CFR 606.171Biological product deviation report
- 21 CFR 640.64(e)Prevention of contamination
Full citation text and observation details available on the Dashboard.
Document or profile
One record shows the event. A profile shows the pattern.
Buy this document for the source file and details behind this single event.
Choose full profile access to connect related records, sites, people, citations, and enforcement history in one view.